tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Strategic Pivot and Promising Clinical Data Justify Buy Rating for Cartesian Therapeutics
PremiumRatingsStrategic Pivot and Promising Clinical Data Justify Buy Rating for Cartesian Therapeutics
3M ago
H.C. Wainwright cuts Cartesian target, calls shares ‘mispriced’
Premium
The Fly
H.C. Wainwright cuts Cartesian target, calls shares ‘mispriced’
3M ago
Strategic Realignment Boosts Cartesian Therapeutics’ Prospects: Gil Blum Issues Buy Rating
Premium
Ratings
Strategic Realignment Boosts Cartesian Therapeutics’ Prospects: Gil Blum Issues Buy Rating
3M ago
Cartesian Therapeutics reports Q3 EPS ($1.38) vs ($1.13) last year
PremiumThe FlyCartesian Therapeutics reports Q3 EPS ($1.38) vs ($1.13) last year
3M ago
Cartesian Therapeutics Announces Leadership Changes
Premium
Company Announcements
Cartesian Therapeutics Announces Leadership Changes
3M ago
Cartesian Therapeutics announces employment inducement grant
Premium
The Fly
Cartesian Therapeutics announces employment inducement grant
3M ago
Cartesian Therapeutics Eliminates Chief Scientific Officer Role
PremiumCompany AnnouncementsCartesian Therapeutics Eliminates Chief Scientific Officer Role
4M ago
Cartesian Therapeutics Appoints New Chief Accounting Officer
Premium
Company Announcements
Cartesian Therapeutics Appoints New Chief Accounting Officer
4M ago
Cartesian Therapeutics announces employment inducement grant
Premium
The Fly
Cartesian Therapeutics announces employment inducement grant
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100